Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
Worldwide Shortage ... Backs Against the Wall ..... UK Co Best in Class ....I don't give a **** if we are waiting approval Buy Buy Buy the Lot say's Boris ...... Just as he did with the Vaccine buy everything he said ..... Just Imagine if this was the conversation LOL
Bioserve selling :
1mg = £1650
https://bioservuk.com/immunoassay-reagents-and-accessories/
So we supply Abcam with Reagents and they in turn supply Abingdon Health for their Lateral Flows ..... How much are these Reagents I think we are missing a trick as to monies already earned :
https://www.abingdonhealth.com/who-we-are/our-partners/
Now have employee's in South Africa ....
https://www.linkedin.com/search/results/people/?currentCompany=%5B%2266603846%22%5D&origin=COMPANY_PAGE_CANNED_SEARCH&page=2&sid=ARr
Now live for Individual's to register / download app ....... part of the registration states avail in App Store .......Once registered issue's unique QR Code etc
https://www.saturnpass.com
So much news coming our way this year
https://www.pointbiopharma.com/our-products/pipeline
https://www.globenewswire.com/news-release/2021/08/13/2280425/0/en/POINT-Biopharma-Reports-Second-Quarter-2021-Financial-Results-and-Provides-Business-Update.html
Out of 18 companies Porges's team looked at, 12 are expected to have more than $20 billion in cash by the end of 2022 when excluding existing debt. Even after factoring in debt, Porges expects Pfizer, Moderna, Johnson & Johnson, Novartis and BioNTech to have net cash of more than $20 billion.
https://www.fiercepharma.com/pharma/m-a-large-biotech-pharma-companies-will-have-1-7t-firepower-for-dealmaking-2022
Download Avacta
http://learning.avactalifesciences.com/delta-app-note?utm_campaign=Covid-19&utm_medium=email&_hsmi=196114355&_hsenc=p2ANqtz--Le11Vq-s7lGDkWgZ8jtaZSaDVM7aXECnOH84N49BRa9bKXscgkZAbRiOPoazz35z9Q5wnRdKPM13cIwQ7MvacGz6dLA&utm_content=196114355&utm_source=hs_email
TEST METHOD
SARS-CoV-2 RT-PCR test
SARS-CoV-2 Delta VOC RT-PCR test
AffiDX® Rapid Antigen Test
Need a good Writer come on someone launch a petition
https://petition.parliament.uk/petitions/new
Perhaps Add ..
LG Chem has successfully completed certain pre-clinical in-vivo models in the PD-L1/XT programme leading to the selection of a pre-clinical candidate for further development towards the clinic and triggering an undisclosed milestone payment.
1st june 2020 have they been working on this in the background all this time could this assist … imagine
Daewoong Pharmaceutical and AffyXell Therapeutics—the joint venture established in South Korea by the two companies—to develop stem cell treatments incorporating Avacta’s neutralizing Affimer therapy to treat seriously ill patients with COVID-19, and prepare to rapidly develop similar therapies for future global pandemics.
Old news but is it dead ?
https://www.genengnews.com/covid-19-candidates/avacta-group/
Imagine if our Affirmers block ?
Avacta said that several of its Affimer reagents block the interaction between the virus’ spike protein and the ACE2 receptor found on human cells. Avacta said the Affimer reagents have the potential to prevent infection and act as “neutralizing” therapies that could be given to those exposed to the virus